Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Perinat Med ; 47(7): 771-774, 2019 Sep 25.
Article in English | MEDLINE | ID: mdl-31487264

ABSTRACT

Background Spina bifida affects 0.5-1 in 1000 pregnancies in the United States and is often diagnosed in the mid-second trimester. The objective of the study was to directly compare ultrasounds (US) and magnetic resonance imaging (MRI) obtained in the antenatal period in the diagnosis and localization of fetal myelomeningocele (MMC) and compare these with the postnatal outcomes of these infants Methods A retrospective analysis of patients referred to the Fetal Care Center at the Cleveland Clinic from 2005 to 2017. US and MRIs were obtained from the Cleveland Clinic electronic medical record. Infants were followed-up at an interdisciplinary myelomeningocele pediatrics clinic. Results MRI and US varied in correlation with physical exam at the time of birth and surgery. While no differences were detected in demographics, pregnancy outcomes or pediatric outcomes, it was noted that the majority of patients developed neurogenic bladders irrespective of the lesion level. Conclusion MRI is not superior to US in the diagnosis of MMC. Pregnancies complicated by MMC do not vary in morbidity, and pediatric outcomes remain similar regardless of the lesion level. This data provides additional information for the counseling of patients when faced with this antenatal diagnosis.


Subject(s)
Magnetic Resonance Imaging/methods , Meningomyelocele , Neurosurgical Procedures/adverse effects , Spine/diagnostic imaging , Ultrasonography, Prenatal/methods , Urinary Bladder, Neurogenic , Adult , Female , Humans , Infant, Newborn , Meningomyelocele/complications , Meningomyelocele/diagnosis , Meningomyelocele/surgery , Neurosurgical Procedures/methods , Pregnancy , Prenatal Diagnosis/methods , Prenatal Diagnosis/standards , Reproducibility of Results , Spine/abnormalities , United States , Urinary Bladder, Neurogenic/diagnosis , Urinary Bladder, Neurogenic/etiology
2.
Obstet Gynecol ; 129(5): 795-799, 2017 05.
Article in English | MEDLINE | ID: mdl-28383385

ABSTRACT

Ohio's governor recently signed into law Senate Bill 127, a bill that makes it a fourth-degree felony for a health care provider to perform an abortion "when the probable post-fertilization age of the unborn child is 20 weeks or greater," joining a series of other states that have enacted such legislation or are moving toward similar legislation. Twenty-week bans have salient implications for women's health, quality of care, and access to services, particularly in the context of the delivery of prenatal care. Because of the timeline of the initiation of prenatal care and assessments of fetal genetic and anatomic anomalies, patients may increasingly find themselves at or near the 20-week postfertilization gestational threshold when they have insufficient information to decide about continuing or ending the pregnancy. This law thus leaves women and families with limited time to obtain a genetic or anatomic diagnosis, restricts access to abortion care at a crucial decision-making time in the pregnancy, and has significant implications for the patient-physician relationship. This law also has ramifications for women and health care providers outside of Ohio, because patients who have made the choice to end a pregnancy will have to cross state lines for abortion care. It is important for obstetric providers to be aware of the ramifications of 20-week bans and take steps to ensure that pregnant women receive high-quality care despite the burdens imposed on the health care decision-making process.


Subject(s)
Abortion, Induced/legislation & jurisprudence , Fetus/abnormalities , Female , Government Regulation , Humans , Legislation, Medical , Ohio , Pregnancy , Pregnancy Trimester, Second
3.
Am J Obstet Gynecol ; 212(5): 647.e1-11, 2015 May.
Article in English | MEDLINE | ID: mdl-25731694

ABSTRACT

OBJECTIVE: The purpose of this study was to investigate the effects of insulin on human placental transcriptome and biological processes in first-trimester pregnancy. STUDY DESIGN: Maternal plasma and placenta villous tissue were obtained at the time of voluntary termination of pregnancy (7-12 weeks) from 17 lean (body mass index, 20.9±1.5 kg/m2) and 18 obese (body mass index, 33.5±2.6 kg/m2) women. Trophoblast cells were immediately isolated for in vitro treatment with insulin or vehicle. Patterns of global gene expression were analyzed using genome microarray profiling after hybridization to Human Gene 1.1 ST and real time reverse transcription-polymerase chain reaction. RESULTS: The global trophoblast transcriptome was qualitatively separated in insulin-treated vs untreated trophoblasts of lean women. The number of insulin-sensitive genes detected in the trophoblasts of lean women was 2875 (P<.001). Maternal obesity reduced the number of insulin-sensitive genes recovered by 30-fold. Insulin significantly impaired several gene networks regulating cell cycle and cholesterol homeostasis but did not modify pathways related to glucose transport. Obesity associated with high insulin and insulin resistance, but not maternal hyperinsulinemia alone, impaired the global gene profiling of early gestation placenta, highlighting mitochondrial dysfunction and decreased energy metabolism. CONCLUSION: We report for the first time that human trophoblast cells are highly sensitive to insulin regulation in early gestation. Maternal obesity associated with insulin resistance programs the placental transcriptome toward refractoriness to insulin with potential adverse consequences for placental structure and function.


Subject(s)
Hypoglycemic Agents/pharmacology , Insulin/pharmacology , Obesity/genetics , Placenta/drug effects , Pregnancy Complications/genetics , RNA, Messenger/drug effects , Transcriptome/drug effects , Trophoblasts/drug effects , Abortion, Induced , Adolescent , Adult , Case-Control Studies , Cells, Cultured , Female , Gene Expression Profiling , Humans , Obesity/metabolism , Placenta/metabolism , Pregnancy , Pregnancy Complications/metabolism , Pregnancy Trimester, First , RNA, Messenger/metabolism , Transcriptome/genetics , Trophoblasts/metabolism , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...